Big Pharma Sues Big Pharma in Biosimilar Cases

Oct 03, 2016

Reuters

Big names including AbbVie, Novartis, Amgen, Sanofi, Merck, Eli Lilly, Pfizer, Johnson & Johnson and Biogen all have been involved in recent lawsuits regarding biosimilar medicines, according to a Reuters article.

Manufacturers are not only protecting their high-priced drugs from biosimilars, but also challenging competitors' patent claims.

The article states that Novartis CEO Joe Jimenez is predicting biosimilar discounts will be up to 75 percent, so makers of these drugs are fighting hard to protect their high-profit products for as long as possible.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments